MIST
Milestone·NASDAQ
--
--(--)
--
--(--)
MIST Filings
Filing Date
Form Description
Form Type
2026-03-26
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-03-26 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-03-23
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2026-03-23 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
2026-03-20
Milestone Pharmaceuticals Inc.(MIST)-20260320-2025 Q4 Earnings call transcript
Earnings Call
2026-03-20 · Earnings Call
Milestone Pharmaceuticals Inc.(MIST)-20260320-2025 Q4 Earnings call transcript
2026-03-20
Form 8-K - Current report
Key Events
2026-03-20 · Key Events
Form 8-K - Current report
2026-03-20
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-03-20 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-02-05
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Ownership
2026-02-05 · Ownership
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
2026-02-05
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Ownership
2026-02-05 · Ownership
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
2026-02-05
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Ownership
2026-02-05 · Ownership
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
2026-02-05
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Ownership
2026-02-05 · Ownership
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
2026-02-05
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Ownership
2026-02-05 · Ownership
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
